Correlation Between Viracta Therapeutics and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viracta Therapeutics and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Viracta Therapeutics and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Verrica Pharmaceuticals.
Diversification Opportunities for Viracta Therapeutics and Verrica Pharmaceuticals
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viracta and Verrica is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viracta Therapeutics and Verrica Pharmaceuticals
Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Verrica Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Viracta Therapeutics is 2.63 times less risky than Verrica Pharmaceuticals. The stock trades about -0.29 of its potential returns per unit of risk. The Verrica Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 160.00 in Verrica Pharmaceuticals on August 31, 2024 and sell it today you would lose (36.00) from holding Verrica Pharmaceuticals or give up 22.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viracta Therapeutics vs. Verrica Pharmaceuticals
Performance |
| Timeline |
| Viracta Therapeutics |
| Verrica Pharmaceuticals |
Viracta Therapeutics and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viracta Therapeutics and Verrica Pharmaceuticals
The main advantage of trading using opposite Viracta Therapeutics and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
| Verrica Pharmaceuticals vs. Cue Biopharma | Verrica Pharmaceuticals vs. Eliem Therapeutics | Verrica Pharmaceuticals vs. Inhibrx | Verrica Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |